[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"icd-malfunction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:icd-malfunction":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,57],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":33,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":4},"100646789","treatment-registry-of-arrhythmias-complications-and-electrocardiograms-in-arrhythmogenic-cardiomyopathies-100646789",false,"NCT07688200","Treatment Registry of Arrhythmias, Complications and Electrocardiograms in Arrhythmogenic CardioMyopathies","Treatment Registry of Arrhythmias, Complications and Electrocardiograms in Arrhythmogenic CardioMyopathies: A Multicenter Retrospective Observational Study","TRACE-ACM","Inclusion Criteria:\n\n* Diagnosis of arrhythmogenic cardiomyopathy, including right-dominant arrhythmogenic right ventricular cardiomyopathy, biventricular arrhythmogenic cardiomyopathy, or left-dominant arrhythmogenic left ventricular cardiomyopathy.\n* ICD implantation.\n* Documented sustained ventricular tachyarrhythmia, including polymorphic ventricular tachycardia, ventricular fibrillation, or monomorphic ventricular tachycardia.\n* Periodic clinical and ICD follow-up.\n* Arrhythmia onset available from ICD electrograms and\u002For ECG recordings.\n* ECG\u002FEGM tracings available for analysis by the steering ECG committee.\n\nExclusion Criteria:\n\n* Incomplete ICD data or incomplete ICD follow-up.\n* Significant coronary artery disease, defined as coronary plaque greater than 50% at coronary angiography or coronary computed tomography angiography.\n* Primary valvular heart disease or congenital heart disease.\n* Infiltrative or inflammatory cardiomyopathies, including sarcoidosis or amyloidosis.\n* Previous exposure to therapies associated with cardiac toxicity, including chemotherapy.","ALL","18 Years",{"count":20,"type":21},300,"ESTIMATED","OBSERVATIONAL","TRACE-ACM is a multicenter, retrospective, observational study of patients with arrhythmogenic cardiomyopathy who received an implantable cardioverter-defibrillator (ICD) and had documented ventricular tachyarrhythmias. The study aims to describe the prevalence and type of ICD-related complications, characterize ventricular arrhythmias documented by ICD electrograms and\u002For ECG recordings, and explore associations between clinical, device-related, and treatment-related factors and arrhythmic outcomes.",[25,26,27,28,29,30,31,32],"Arrhythmogenic Cardiomyopathy (AC, ARVD\u002FC)","Ventricular Tachycardia (VT)","Ventricular Fibrillation","ICD","ICD Malfunction","ICD SHOCKS","Ventricular Arrhythmias and Cardiac Arrest","Ventricular Arrhythmia",[34,35,36,37,38,39,40,41,42,43,44],"Implantable cardioverter-defibrillator","ICD complications","Arrhythmogenic cardiomyopathy","Monomorphic ventricular tachycardia","Polymorphic ventricular tachycardia","Ventricular fibrillation","ICD electrograms","Arrhythmic storm","Pause-dependent arrhythmia initiation","Catheter ablation","Antiarrhythmic drugs","NOT_YET_RECRUITING","2026-06-30",{"date":48,"type":49},"2026-07-07","ACTUAL",{"date":51,"type":21},"2026-07-01",{"date":53,"type":21},"2027-12-31",{"name":55,"class":56},"Policlinico Casilino ASL RMB","OTHER",{"id":58,"slug":59,"hasResults":11,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":65,"targetDuration":67,"studyType":22,"phases":4,"briefSummary":68,"conditions":69,"keywords":74,"overallStatus":79,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":5},"100387938","perioperative-management-evaluation-in-patients-with-cied-100387938","NCT04331249","Perioperative Management Evaluation in Patients With CIED","Perioperative Management Evaluation in Patients With Implanted Cardiac Electronic Devices","EVINCE","Inclusion Criteria:\n\n* implanted CIED (e.g. pacemaker, ICD, CRT),\n* performed (non-CIED related) surgical or catheter-based procedure,\n* data from peri-procedural CIED interrogation available\n* age \\>18 years\n\nExclusion Criteria:\n\n* no implanted CIED,\n* no data from any peri-interventional CIED interrogation available",{"count":66,"type":21},500,"1 Month","Background: Recommendations for peri-operative management in patients with implanted cardiac electronic devices (CIED) are often based on older data from case reports and small collectives.\n\nObjective: To evaluate the peri-operative management and outcome of patients with implanted CIED undergoing non-CIED related surgery or catheter-interventional procedures in clinical routine.\n\nStudy design: bi-center, non-randomized, observational registry, retrospective data-collection, on-going prospective patient enrollment, descriptive statistics\n\nPrimary endpoint: number and type of peri-operative adverse device related events (ADE) Secondary endpoints: pre-interventional data (patient characteristics, data from CIED interrogation); peri-interventional data (type of surgery\u002Fintervention, anesthesiology techniques, any AE), postinterventional data (data from post-interventional CIED interrogation, need for reprogramming \u002F device revision).\n\nInclusion criteria: implanted CIED, non-CIED related surgical or catheter-based intervention, peri-procedural CIED interrogation, age \\>18 years Exclusion criteria: no implanted CIED, no data from any peri-procedural CIED interrogation available\n\nPatient enrollment: retrospectively beginning from 2008, further on-going prospective inclusion Sample size: For the observational study, there is no pre-specified sample size. Data from more than 500 patients undergoing \\> 700 interventions are expected.",[70,29,71,72,73],"Cardiac Pacemaker Malfunction","Cardiac Pacemaker Electrical Interference","Anesthesia Complication","Surgery--Complications",[75,76,77,78],"pacemaker","implanted cardioverter defibrillator","cardiac resynchronisation therapy","management, peri-operative","RECRUITING","2024-10-11",{"date":82,"type":49},"2024-10-15",{"date":84,"type":49},"2018-11-27",{"date":86,"type":21},"2030-12-31",{"name":88,"class":56},"Klinikum-Fuerth"]